Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Heves Surmeli"'
Autor:
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Ozkan Alan, Sermin Coban Kokten, Deniz Isik, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Hatice Odabas, Mahmut Emre Yildirim, Nedim Turan
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Neoadjuvant chemotherapy (NACT) is the standard treatment for locally advanced, high-risk breast cancer. Pathological complete response (pCR) improves survival. Peripheral blood-derived indices reflecting systemic inflammation and nutritiona
Externí odkaz:
https://doaj.org/article/1a1cba80adca4b45bbb0a31a1f079759
Autor:
Goncagul Akdag, Deniz Isik, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Alper Topal, Sila Oksuz, Ezgi Turkoglu, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Hatice Odabas, Mahmut Emre Yildirim, Nedim Turan
Publikováno v:
Medicina, Vol 60, Iss 8, p 1372 (2024)
Background and Objectives: Colorectal cancer (CRC) poses a major global health challenge, with high incidence rates and ongoing treatment debates. Adjuvant chemotherapy benefits for high-risk subgroups, particularly stage II disease, remain controver
Externí odkaz:
https://doaj.org/article/6320822833324fba8255b91244490237
Autor:
Sedat Yildirim, Ozkan Alan, Zeynep Yuksel Yasar, Tugba Kaya, Goncagul Akdag, Oguzcan Kinikoglu, Gonca Gul Gecmen, Alper Yasar, Deniz Isik, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Mahmut Emre Yildirim, Hatice Odabas, Nedim Turan
Publikováno v:
Medicina, Vol 60, Iss 8, p 1374 (2024)
Background and Objectives: Lung cancer is the leading cause of cancer-related deaths. Spread through air spaces (STAS) is an adverse prognostic factor that has become increasingly known in recent years. This study aims to investigate the impact of ST
Externí odkaz:
https://doaj.org/article/448842896a04478c96a4f27fea588dd4
Publikováno v:
Eurasian Journal of Medical Investigation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab06df6499462760fee72ba7621b8193
https://doi.org/10.14744/ejmi.2020.30288
https://doi.org/10.14744/ejmi.2020.30288
Autor:
Deniz Işık, Oğuzcan Kınıkoğlu, Goncagül Akdağ, Yunus Emre Altıntaş, Ezgi Türkoğlu, Sedat Yildirim, Heves Sürmeli, Tuğba Başoğlu, Hatice Odabaş, Nedim Turan
Publikováno v:
Medicina, Vol 60, Iss 7, p 1088 (2024)
Background: The treatment and escape for metastatic renal cell carcinoma (RCC) has rapidly evolved, particularly with the integration of immune therapies into first-line regimens. However, optimal strategies following progression in first-line immuno
Externí odkaz:
https://doaj.org/article/9b549c3d6d49476285fb0a85aad8e5af
Autor:
Ozgur Tanriverdi, Serkan Menekse, Faysal Dane, Mukremin Uysal, Metin Ozkan, Halit Karaca, Mehmet Besiroglu, Ibrahim Vedat Bayoglu, Ayse Ocak Duran, Dogan Yazilitas, Alper Sevinc, Ilhan Hacibekiroglu, Erkan Arpaci, Aykut Bahceci, Mevlude Inanc, Heves Surmeli Yapici, Asude Aksoy
WOS: 000351058400056
PubMed ID: 25556478
Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this s
PubMed ID: 25556478
Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4644b7109f838e680f4e4429b7551933
https://hdl.handle.net/20.500.12809/3548
https://hdl.handle.net/20.500.12809/3548
Autor:
Eyup Ozpolat, Oya Uygur Bayramiçli, Can Dolapcioglu, Basak Boynuegri, Heves Surmeli, Zerrin Bicik Bahcebasi, Emel Ahishali, Resat Dabak
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 36:139-145
Summary Background Mushroom is widely consumed in Turkey because it is inexpensive and widely available. Intoxication with mushroom is a common health problem in Turkey with a high mortality rate. Aim To identify the outcome of patients with wild mus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5d8068708cc0df5c32652205eaa4de
https://doi.org/10.1016/j.clinre.2011.11.004
https://doi.org/10.1016/j.clinre.2011.11.004
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.